Johnite.net

...home of the St. Johns Medical College Community

  • Increase font size
  • Default font size
  • Decrease font size
Home

Dr Chris De Souza appointed as Editor In Chief of the International Journal of Head and Neck Surgery

E-mail Print PDF

Dr Chris De Souza has been appointed as the Editor in chief of the International Journal of Head and Neck Surgery.

 Dr. Chris deSouza is a Consultant Neurosurgeon at the TATA Memorial Hospital and consultant ENT Surgeon at the Holy Family Hospital (Bandra), Holy Spirit Hospital and Lilavati Hospital, Bandra(W). He is also a Visiting Assistant Professor in Otolaryngology at the State University of New York, USA and the State University of Louisiana, Shreveport, USA. He has published many research papers overseas and is the author of many text books on neurology and ENT

Why another journal?, would be a logical question in the mind of readers who have scores of journals available in the literature, in addition to internet based sources to acquire knowledge, and new information. The plethora of printed journals currently available in the specialty of Medicine, Surgery, Oncology, and Head and Neck, would create a sense of redundancy by introducing yet another journal in the specialty of Head and neck Surgery and Oncology. However, JAYPEE publishers and Drs. Chris de Souza and Pankaj Chaturvedi, are to be complemented to take the challenge of introducing the International Journal of Head and Neck Surgery. Needless to say, they have several reasons to justifyit’s introduction.

The rising cost of producing hard copy journals in the western world, has made it almost impossible, for physicians and trainees in many parts of the world, to have access to established journals, depriving them the opportunity to learn, educate and remain up to date in a timely fashion. This is particularly true for the Indian sub continent. The publishers are to be commended to introduce this “low cost” journal, with high quality printing, and even color printing of artwork and pictures at no cost to the authors. This is an offer, which is hard to match by any of the journals produced from the western world. The rapidly expanding knowledge base in the areas of clinical care, technological advances and basic research demand more and newer venues, to publish the new information for dissemination of such in an expeditious manner. The quick turnaround time promised by the Editors is indeed enlightening, and should stimulate prospective authors to submit their important works to this journal.

The International Editorial Board, of this journal comprises of a list of individuals, who truly are amongst the world leaders in the specialty. Their cumulative knowledge, experience and wisdom would be a solid strength of this journal. The National Editorial Board comprises of individuals who are amongst the established and rising stars in our specialty , in the nation. Needless to say, the Editorial Board will continue to change and recruit more individuals with new areas of expertise to strengthen the journal further. The challenge for the Editorial Board will be to critically review, and publish articles providing new knowledge in a timely fashion. Introducing new fora to the journal such as ‘journal scan’, and collective reviews, opinion columns and pro /con debates will certainly make this journal a worthwhile read.

This journal will offer a new means for publication of their works for rapid dissemination to prospective authors, and a pleasing and attractive printed medium for readers to acquire new information. While the scope and reach of the journal remains ‘International’, in the long term, it certainly will create a significant impact in South East Asia in general and the Indian sub continent in particular. I commend the Publishers and Editors for their laudable initiative, and congratulate them for this important contribution to the specialty of Head and Neck Surgery.

Jatin P. Shah, MD, PhD (Hon), FACS, FRCS(Hon), FRACS(Hon), FDSRCS(Hon).
Professor of Surgery,
E W Strong Chair in Head and Neck Oncology,
Chief, Head and Neck Program,
Memorial Sloan Kettering Cancer Center,
New York, NY. USA

http://www.ijhns.com/Eboard.aspx

 

New Book By Dr Paul Thuluvath not yet released

E-mail Print PDF

Liver and Endoscopy, An Issue of Clinics in Liver Disease

Gastrointestinal endoscopy plays an essential role in the management of patients with liver disease. This issue reviews the standard of care in the endoscopic management of portal hypertension and biliary disease before and after liver transplantation. A thorough knowledge of the available endoscopic diagnostic and therapeutic methods is essential for the practicing hepatologist. Emphasis is placed on recent advances in imaging techniques such as the application of capsule endoscopy and endoscopic ultrasound in the evaluation of portal hypertension and recent advances in cholangioscopy and biliary tissue sampling. Additionally new information regarding the endoscopic management of esophageal and gastric varices is reviewed. Finally, the current role of ERCP in the diagnosis and staging of cholangiocarcinoma before liver transplantation and the endoscopic management of biliary complications after liver transplantation is discussed

ABOUT DR. THULUVATH... Paul J. Thuluvath, M.D., completed an internship and residency in Internal Medicine at St. Johns Medical College Hospital, India, as well as a residency in Internal Medicine at the Dunston Hill Hospital and Castle Hill Hospital, England. He completed his Gastroenterology and Hepatology fellowship at the University of Cambridge, England. Board Certified in Gastroenterology and Internal Medicine, Dr. Thuluvath specializes in liver disease, liver transplantation, ERCP, liver cancer, and primary sclerosing cholangitis. He extensive research experience, has authored numerous articles, book chapters, and editorials, and is an international speaker. A fellow of the American College of Gastroenterology and Royal College of Physicians of London, Dr. Thuluvath is a member of the American Association for Study of Liver Disease, American Gastrenterological Association, American Society for Gastrointestinal Endoscopy, International Liver Transplant Society, The Transplantation Society, and European Association for Study of Liver Diseases.

 

 

The Prestigous Moynihan Prize Awarded to Dr Dileep Lobo and Research Fellow

E-mail Print PDF

Winner of the 2010 Moynihan Prize:
CELLULAR MECHANISMS UNDERLYING THE PROTECTIVE EFFECTS OF PREOPERATIVE FEEDING: A RANDOMIZED STUDY INVESTIGATING MUSCLE AND LIVER GLYCOGEN CONTENT, MITOCHONDRIAL FUNCTION AND GENE EXPRESSION


S Awad*, D Constantin-Teodosiu, K C H Fearon, I A Macdonald and D N Lobo (Nottingham and Edinburgh)

This paper has also been accepted to be published in The Annals of Surgery

This is the Association’s most prestigious scientific award. The award consists of £1,000 together with a medal and is presented to the author of the best research work delivered at the International Surgical Congress.

The person reading the paper must be the principal research worker and have been qualified for less than fifteen years. In the case of multiple-author papers, the Medal will be presented to the person reading the paper and the award may be divided between authors.

The paper should have a scientific basis and clinical application; case reports and audit reports should not be submitted. The paper must not have been submitted previously to any other national or international association nor published in any Journal at the time of submission. Shortlisted papers which are found to have been presented elsewhere, or have been accepted for presentation elsewhere, will be disqualified.

If selected, competitors are encouraged to submit a manuscript suitable for publication. The Moynihan Prize paper shall become the property of the Association and will be published on the British Journal of Surgery's website (citable) and in the ASGBI Abstract Book.

http://www.asgbi.org.uk/liverpool/moynihan_prize.htm#moynihan_winner_new

 

Barretts Surveillance Identifies Patients with Early Esophageal Carcinoma

E-mail Print PDF

Barrett's Surveillance Identifies Patients with Early Esophageal Adenocarcinoma

Article in the American  Journal of Medicine

 

Timothy Wong, MDa, Jianmein Tian, MDb, Anil Bernard Nagar, MDcd

See full size image

 

 

 

Abstract 

Background

Barrett's surveillance for dysplasia is recommended, but few studies have documented the benefit of endoscopic surveillance for dysplasia or cancer.

Objectives

Using a retrospective study design, we aim to demonstrate the impact of a Barrett's surveillance program on the stage of esophageal adenocarcinoma and identify factors for progression of metaplasia to cancer.

Subjects

The Institutional Review Board at Veterans Affairs Connecticut Healthcare approved the study. We report a retrospective review of a prospectively followed Barrett's cohort in a surveillance program and compared their outcome with patients with a new diagnosis of esophageal adenocarcinoma, identified at the same center between 1999 and 2005.

Results

There were 248 patients with Barrett's esophagus entered into a surveillance program from 1999 to 2005. During the surveillance period of 987 patient-years, 5 (0.5% patient-year) patients developed esophageal adenocarcinoma. During the same period, 46 patients were diagnosed with new-onset esophageal adenocarcinoma outside of our surveillance program. Only 5% of these patients had a history of gastroesophageal reflux disease. There were 248 patients who underwent a mean number of 2.7±1.7 upper endoscopic procedures, with 26 (10%) patients developing dysplasia. Compared with nonsurveillance, more patients had early stage of cancer in the surveillance group (P 3 cm was found to be associated with development of dysplasia, P=.004 (odds ratio 1.2; 95% confidence interval, 1.07-1.34).

Conclusion

Patients with Barrett's esophagus undergoing endoscopic surveillance benefit from early-stage cancer diagnosis. Progression to adenocarcinoma is low, but long-segment and high-grade dysplasias have an increased risk of cancer. A significant number of patients with newly diagnosed esophageal adenocarcinoma do not complain of gastroesophageal reflux disease and are therefore not investigated for Barrett's esophagus nor entered into surveillance. Patients and physicians can use this information in making a decision about surveillance.

a Winthrop-University Hospital, Mineola, NY

b Department of Gastroenterology, Mayo Clinic, Rochester, Minn

c Department of Medicine, Section of Digestive Disease, Yale University School of Medicine, New Haven, Conn

d West Haven Veterans Affairs Medical Center, West Haven, Conn

Requests for reprints should be addressed to Anil Nagar, MD, Department of Internal Medicine, Section of Digestive Diseases, Yale University School of Medicine, 1080 LMP, 333 Cedar Street, New Haven, CT 06520

 Funding: None.

 Conflict of Interest: The authors state that they have no conflicts of interest.

 Authorship: All authors had access to the data and contributed to study design, data acquisition, and data analysis. All authors were involved in manuscript writing.

PII: S0002-9343(09)01109-7

doi:10.1016/j.amjmed.2009.10.013

 

The Passing of Dr Denzil Lobo

E-mail Print PDF

Dr Denzil Lobo passed away peacefully on May 2nd 2010.He is survived by his wife Joan and siblings

Last respects and public viewing on May 4th 2010 at 2.45 pm at Saint Francis Church Bejia Mangalore india with mass following at 3.45pm

He will be missed by all Johnites who knew him especially the Johnites from B Block.He was kind ,considerate and fun loving.

dr denzil lobo

 


Page 4 of 29